How do I calculate the paraprotein gap and determine if it is elevated?

How to calculate and interpret an elevated paraprotein (gamma) gap

Bold recommendation: Calculate the paraprotein (gamma) gap as Total Serum Protein − Serum Albumin; a value ≥4.0 g/dL (≥40 g/L) is “elevated” and justifies targeted testing for monoclonal gammopathy or chronic infection, but a normal gap does NOT exclude these conditions 1.

Step 1 — Calculate the paraprotein (gamma) gap

• Use same-day serum values:
  • Paraprotein (gamma) gap = Total Protein − Albumin
  • Units:
    • g/dL: Elevated if ≥4.0 g/dL
    • g/L: Elevated if ≥40 g/L
• If only “calculated globulin” (CG) is reported, CG = Total Protein − Albumin; it equals the gamma gap.

Step 2 — Determine if it’s elevated

• Thresholds supported by population data:
  • ≥4.0 g/dL (≥40 g/L): High specificity for HIV/HCV; poor sensitivity for MGUS/MM; do not use alone to rule in MM 1.
  • Around ≥3.8 g/dL (≥38 g/L): Balanced sensitivity/specificity for hypergammaglobulinemia on SPEP but still imperfect; high NPV for ruling out significant gammopathy in general lab populations 2.
• Practical cut:
  • Use ≥4.0 g/dL to minimize false positives.
  • Consider 3.8–4.0 g/dL “borderline high” if clinical suspicion is strong.

Step 3 — Act on the result (to protect morbidity, mortality, QOL)

• If gamma gap ≥4.0 g/dL OR strong clinical suspicion (bone pain, anemia, renal dysfunction, hypercalcemia, recurrent infections, neuropathy):
  • Order:
    • Serum protein electrophoresis (SPEP) with immunofixation (SIFE) — preferred for identifying M-protein 3, 4.
    • Serum free light chains (sFLC) with κ/λ ratio — essential for light-chain disease and “light-chain escape” 3.
    • Consider 24-h urine protein electrophoresis with immunofixation if serum non-diagnostic 3.
• If gamma gap normal but red flags for myeloma exist:
  • Still proceed with SPEP/SIFE and sFLC; normal gap does NOT exclude MGUS/MM and missing MM risks renal failure, fractures, and early mortality 3, 1.

Interpretation nuances and pitfalls

• A high gap is nonspecific:
  • Can reflect polyclonal gammopathy (infection, autoimmune disease), dehydration, or lab method differences; use confirmatory testing 2, 1.
• Not sensitive for MM/MGUS:
  • Do not use the gap to rule out monoclonal gammopathy; rely on IMWG-recommended assays for diagnosis/monitoring to impact outcomes 3, 1.
• Method consistency:
  • When tracking immunoglobulins, use the same lab platform; immunoturbidimetric values vary by analyzer and can mislead trends affecting care decisions 4.
• Free light chain myeloma:
  • Gap/CG may be normal; sFLC is mandatory if suspected (AKI with proteinuria but bland albumin, bone pain, unexplained anemia) to avert renal morbidity 3, 5.

Why this approach

• Guideline priority:
  • IMWG/ASCO-CCO: follow measurable monoclonal parameters (SPEP/SIFE, sFLC) and confirm changes to guide treatment that improves survival and QOL 3.
• Evidence on the gamma gap:
  • ≥4.0 g/dL has high specificity but low sensitivity for HIV/HCV and MGUS; absence of elevation does not rule out disease; use as a trigger, not a screen 1.
  • PG around ≥38 g/L moderately detects hypergammaglobulinemia; high NPV helps deprioritize in low-suspicion settings, but not sufficient to miss MM workup when clinical concern exists 2.
  • Calculated globulin can flag MM in primary care but misses light-chain MM; thus it augments, not replaces, guideline diagnostics to prevent delayed care 5.

Quick algorithm

• Compute gap = Total Protein − Albumin.
  • If ≥4.0 g/dL (≥40 g/L): order SPEP/SIFE + sFLC; consider urine studies 3, 1.
  • If 3.8–3.9 g/dL with symptoms/labs suggestive of MM: same as above 3, 2.
  • If <3.8 g/dL but high clinical suspicion (CRAB features, unexplained cytopenias, bone pain, renal injury): still order SPEP/SIFE + sFLC to avoid missed MM 3, 1.
• Always interpret confirmatory results per IMWG criteria and confirm laboratory changes before altering therapy to impact morbidity/mortality/QOL 3.